SMS Pharmaceuticals Ltd — Capital/Financing Update 2025

Jun 17, 2025

==> picture [241 x 158] intentionally omitted <==

Date : 17[th] June, 2025

To The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai Mumbai- 400 001 - 400 051. Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

• Sub: Intimation of Listing & Trading approval received from BSE Limited and National Stock Exchange of India Limited (NSE) for 40,00,000 equity shares of Rs. 1/- each issued at a premium of Rs.126/- to Promoters/promoters group on a preferential basis pursuant to conversion of warrants

Ref: Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

We would like to inform you that the Company has received Trading approval for 40,00,000 Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis from BSE Limited and National Stock Exchange of India Limited (NSE) and the above mentioned equity shares are listed and admitted to dealings on the Exchanges with effect from Wednesday, June 18, 2025.

The approval Letters received from BSE Limited and NSE are enclosed herewith.

We request you to take the above information on record.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2025.06.17 19:09:50 +05'30'

Thirumalesh Tumma Company Secretary

" E - Letter " Tuesday, June 17, 2025

==> picture [107 x 30] intentionally omitted <==

LOD / PREF / SV / 367/ 2025-2026

The Company Secretary SMS Pharmaceuticals Ltd

Plot. No; 72, H, H. No; 8-2-334/3&4, Road. No: 5, Banjara Hills, Hyderabad, Telangana, 500034.

Dear Sir / Madam,

- - Re: Trading of 4000000 Equity Shares of Rs. 1.00/ each to be issued at a premium of Rs. 126.00/ bearing distinctive numbers from 84652031 to 88652030 issued to Promoters on a preferential basis pursuant to conversion of warrants.

We acknowledge with thanks the receipt of your application and subsequent submissions and have pleasure in advising that effective from Wednesday, June 18, 2025 the above-mentioned securities are listed on the Exchange.

Please refer our Notice No. 20250617-15 dated June 17, 2025 available on our website issued in this behalf to the Trading Members of the Exchange, for your information, the contents of which may please be checked and confirmed to the Exchange.

Yours faithfully,

SD/Sabah Vaze Assistant Vice President

==> picture [566 x 81] intentionally omitted <==

==> picture [452 x 105] intentionally omitted <==

Ref.: NSE/LIST/ 49056 June 17, 2025

The Company Secretary SMS Pharmaceuticals Limited Plot No. 72, H.No. 8-2-334/3&4, Road No.5 Opp. SBI Executive enclave Banjara Hills, Hyderabad-500034

Dear Sir/Madam,

Sub: Listing of further issue on Preferential Issue

This is with reference to the application for the listing of further issue of 4000000 Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis made by the company. We are pleased to inform you that the above equity shares of the Company are listed and admitted to dealings on the Exchange from June 18, 2025 as per the details given below:

Sr. No.	Security Description	Symbol	Series	No. of securities	Distinctive Numbers
1.	Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis	SMSPHARMA	EQ	4000000	84652031 to 88652030

You are requested to note that as per the information provided by you, the lock-in details are mentioned in Annexure I.

Please note that all critical/price sensitive information and other submissions under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 shall be provided by the company through ‘NEAPS’ – NSE Electronic Application Processing System (https://neaps.nseindia.com/NEWLISTINGCORP/), an online filing facility provided by the Exchange, for quicker and efficient processing of your submissions.

If you require any further clarifications, we shall be glad to oblige.

Yours faithfully, For National Stock Exchange of India Limited

Srishti Soni Manager

CC:	National Securities Depository Limited	Central Depository Services Limited
	4th Floor, Trade world,	Marathon Futurex, A-Wing, 25th floor,
	Kamala Mills Compound,	N M Joshi Marg, Lower Parel,
	Senapati Bapat Marg.,	Mumbai – 400 013
	Lower Parel, Mumbai - 400 013

P.S. Checklist of all the further issues is available on website of the exchange at the following URL: https://www.nseindia.com/companies-listing/raising-capital-further-issues-main-sme-checklist

==> picture [452 x 42] intentionally omitted <==

Continuation Sheet

==> picture [294 x 71] intentionally omitted <==

Annexure I SMS Pharmaceuticals Limited

No. of Shares	Distinctive Numbers Range	Distinctive Numbers Range	Date upto which lock-in
	From	To
4000000	84652031	88652030	30-Mar-2027
4000000	Total

==> picture [452 x 42] intentionally omitted <==